Keyphrases
Intraductal Papillary mucinous Neoplasm
100%
Adverse Outcomes
100%
Tumor Grade
100%
Epithelial-to-mesenchymal Transition
100%
MicroRNA
20%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
20%
Metastasis
13%
Quantitative PCR
6%
Deregulation
6%
Differentially Expressed
6%
High Risk
6%
Tumor
6%
Malignancy
6%
Tumorigenesis
6%
Poor Prognosis
6%
Hierarchical Clustering
6%
Pancreatic Tissue
6%
Tissue Sampling
6%
Gastrointestinal
6%
Tumor Samples
6%
Immunohistochemical Analysis
6%
Surgical Specimen
6%
Tumor Specimens
6%
Adverse Clinical Outcomes
6%
Lymph Node Metastasis
6%
Novel Biomarkers
6%
E-cadherin
6%
Cadherin
6%
Vimentin
6%
Pathologist
6%
Vimentin Expression
6%
Western Blot Assay
6%
MiR-200c
6%
Tumor Aggressiveness
6%
E-cadherin Expression
6%
Differentially Expressed mRNAs (DEmRNAs)
6%
Human miRNAs
6%
MiR-141
6%
Transition Characteristics
6%
Intraductal Papillary mucinous Carcinoma
6%
Medicine and Dentistry
Neoplasm
100%
Intraductal Papillary Mucinous Tumor
100%
Adverse Outcome
100%
Mesenchymal-Epithelial Transition
100%
microRNA
33%
Biological Marker
13%
Metastatic Carcinoma
13%
Vimentin
13%
Uvomorulin
13%
Carcinogenesis
6%
Real-Time Polymerase Chain Reaction
6%
Cancer
6%
Lymph Node Metastasis
6%
Carcinoma
6%
Western Blot
6%
Pathologist
6%
microRNA 200c
6%
microRNA 141
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Adverse Outcome
100%
Intraductal Papillary Mucinous Tumor
100%
microRNA
33%
Biological Marker
13%
Uvomorulin
13%
Vimentin
13%
Western Blot
6%
Carcinogenesis
6%
Lymph Node Metastasis
6%
Carcinoma
6%
microRNA 200c
6%
microRNA 141
6%
Immunology and Microbiology
Epithelial Mesenchymal Transition
100%
Cadherin
22%
Western Blot
11%
Real-Time Polymerase Chain Reaction
11%
Lymph Node
11%